Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
A quick update re: yesterday’s bonus communication day, the update being that Brady Dougan apparently has some ticked off junior mistmakers on his hands.
“Equity research bonuses dismal despite record turnover in 2013 among junior and senior covering analysts. Management continues to de-emphasize equity research. Resumes are being updated. Morale reaches new low ahead of move into smaller offices.
Some got a kicker from their bosses but in many cases bosses were underpaid as well in has been ironically dubbed an “investment” year by the firm after record turnover in 2013. People who got zero also received a ‘sorry’.”